TTOO — T2 Biosystems Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.02m
- $9.86m
- $7.19m
Brief: T2 Biosystems Announce Participation In NIH-Funded Antibacterial Resistance Leadership Group Pilot Study For Pneumonia Patients
Brief: T2 Biosystems Regains Compliance With Nasdaq Listing Requirements
Brief: T2 Biosystems Announces Amendment And Extension Of Crg Term Loan Agreement
U.S. STOCKS ON THE MOVE-Silver miners, Instacart, Incyte
U.S. STOCKS ON THE MOVE-Energy sector, Sigma Additive Solutions, Newmont Corp
U.S. STOCKS ON THE MOVE-T2 Biosystems, Dollar General, Wells Fargo
U.S. STOCKS ON THE MOVE-UnitedHealth Group, Wells Fargo, oil companies
T2 Biosystems plunges on downbeat Q3 prelim revenue
Brief: T2 Biosystems Q3 revenue USD 1.5 million
T2 Biosystems Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: T2 Biosystems Regains Compliance With Nasdaq’S Market Value Of Listed Securities Requirement
U.S. STOCKS ON THE MOVE-DISH Network, Lisata Therapeutics, WeightWatchers
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
T2 Biosystems Inc expected to post a loss of 27 cents a share - Earnings Preview
Brief: T2 Biosystems Receives Extension To Comply With Nasdaq Listing Requirements
Brief: T2 Biosystems Receives FDA Breakthrough Device Designation For Candida Auris Diagnostic Test
U.S. RESEARCH ROUNDUP-Paccar, PennyMac Financial Services, Progressive
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy